These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27742115)

  • 21. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
    Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
    Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current technological advances in magnetic resonance with critical impact for clinical diagnosis and therapy.
    Runge VM
    Invest Radiol; 2013 Dec; 48(12):869-77. PubMed ID: 24126386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular imaging with targeted contrast agents.
    Makowski MR; Wiethoff AJ; Jansen CH; Botnar RM
    Top Magn Reson Imaging; 2009 Aug; 20(4):247-59. PubMed ID: 20805735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
    Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
    Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.
    Mulder WJ; Strijkers GJ; van Tilborg GA; Griffioen AW; Nicolay K
    NMR Biomed; 2006 Feb; 19(1):142-64. PubMed ID: 16450332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlling RNA Expression in Cancer Using Iron Oxide Nanoparticles Detectable by MRI and In Vivo Optical Imaging.
    Medarova Z; Balcioglu M; Yigit MV
    Methods Mol Biol; 2016; 1372():163-79. PubMed ID: 26530923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A multislice gradient-echo sequence for contrast medium-enhanced MR diagnosis of intracranial tumors].
    Schörner W; Sander B; Kornmesser W; Laniado M; Nakamura T; Felix R
    Rofo; 1988 Jun; 148(6):665-73. PubMed ID: 2837804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-photon emission computed tomography/computed tomography in brain tumors.
    Schillaci O; Filippi L; Manni C; Santoni R
    Semin Nucl Med; 2007 Jan; 37(1):34-47. PubMed ID: 17161038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposomal nanocarriers for tumor imaging.
    Erdogan S
    J Biomed Nanotechnol; 2009 Apr; 5(2):141-50. PubMed ID: 20055092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery.
    Kohler N; Sun C; Fichtenholtz A; Gunn J; Fang C; Zhang M
    Small; 2006 Jun; 2(6):785-92. PubMed ID: 17193123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticles as computed tomography contrast agents: current status and future perspectives.
    Shilo M; Reuveni T; Motiei M; Popovtzer R
    Nanomedicine (Lond); 2012 Feb; 7(2):257-69. PubMed ID: 22339135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-Atlas-Based Attenuation Correction for Brain 18F-FDG PET Imaging Using a Time-of-Flight PET/MR Scanner: Comparison with Clinical Single-Atlas- and CT-Based Attenuation Correction.
    Sekine T; Burgos N; Warnock G; Huellner M; Buck A; Ter Voert EE; Cardoso MJ; Hutton BF; Ourselin S; Veit-Haibach P; Delso G
    J Nucl Med; 2016 Aug; 57(8):1258-64. PubMed ID: 27013697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery.
    Langereis S; Geelen T; Grüll H; Strijkers GJ; Nicolay K
    NMR Biomed; 2013 Jul; 26(7):728-44. PubMed ID: 23703874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic contrast-enhanced imaging techniques: CT and MRI.
    O'Connor JP; Tofts PS; Miles KA; Parkes LM; Thompson G; Jackson A
    Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S112-20. PubMed ID: 22433822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics.
    Fattahi H; Laurent S; Liu F; Arsalani N; Vander Elst L; Muller RN
    Nanomedicine (Lond); 2011 Apr; 6(3):529-44. PubMed ID: 21542690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and quality test of superparamagnetic iron oxide labeled antisense oligodeoxynucleotide probe: a preliminary study.
    Wen M; Li B; Ouyang Y; Luo Y; Li S
    Ann Biomed Eng; 2009 Jun; 37(6):1240-50. PubMed ID: 19337837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced MR Imaging in Pediatric Brain Tumors, Clinical Applications.
    Lequin M; Hendrikse J
    Neuroimaging Clin N Am; 2017 Feb; 27(1):167-190. PubMed ID: 27889022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence-Guided Probes of Aptamer-Targeted Gold Nanoparticles with Computed Tomography Imaging Accesses for in Vivo Tumor Resection.
    Li CH; Kuo TR; Su HJ; Lai WY; Yang PC; Chen JS; Wang DY; Wu YC; Chen CC
    Sci Rep; 2015 Oct; 5():15675. PubMed ID: 26507179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrepancy between the dynamic computed tomography and T2 magnetic resonance perfusion imaging in brain tumors: a report of 2 cases.
    Li YD; Geng DY; Zhang QB; Jiang SH
    J Comput Assist Tomogr; 2007; 31(6):896-900. PubMed ID: 18043353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory bowel disease: MR- and SPECT/CT-based macrophage imaging for monitoring and evaluating disease activity in experimental mouse model--pilot study.
    Wu Y; Briley-Saebo K; Xie J; Zhang R; Wang Z; He C; Tang CY; Tao X
    Radiology; 2014 May; 271(2):400-7. PubMed ID: 24475849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.